Trial intelligence / Profile preview

Phase II randomized double-blind placebo-controlled pilot study of intravesical PSD597 for interstitial cystitis/painful bladder syndrome

ISRCTN56132730Phase 2Completed

Sponsor
Plethora Solutions
Start
Jul 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of Lidocaine + sodium bicarbonate in Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS), sponsored by Plethora Solutions. Started Jul 2006; status: completed.

02

Drugs

Lidocaine + sodium bicarbonate
03

Conditions

Interstitial Cystitis-Bladder Pain Syndrome (IC/BPS)

Beyond the preview

Go deeper on ISRCTN56132730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN56132730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call